Found 42 matching trials
A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With EGFR-Positive Advanced Non-Small Cell Lung Cancer
PHASE2The objective of this study is to assess the efficacy, safety of MRG003 as ...
Location
Cancer Hospital Chinese Academy of Medical Sciences
ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer
PHASE1This is a single-arm, multicenter, phase II study designed to evaluate the ...
Location
Multiple Locations
ADC and SBRT for Recurrent/Metastatic Salivary Gland Carcinoma
PHASE2This is a single-arm, single-center, exploratory clinical study. The study ...
Location
Multiple Locations
Neoadjuvant Pucotenlimab and Becotatug Vedotin for Locally Advanced Penile Cancer
PHASE2This is an open-label, multicenter, single-arm Phase 2 clinical trial evalu...
Location
Sun Yat-sen University Cancer Center
Becotatug Vedotin Plus Pucotenlimab for Advanced Biliary Tract Cancer, Phase II
PHASE2Biliary tract carcinoma (BTC), including cholangiocarcinoma and gallbladder...
Location
Multiple Locations
Phase II Study of Becotatug Vedotin Plus Pucotenlimab for Advanced Refractory Solid Tumors With EGFR-Positive
PHASE2This phase II trial evaluates the combination of Becotatug Vedotin (MRG003)...
Location
Tianjin Medical Unversity Second Hospital
Neoadjuvant Presurgical Becotatug Vedotin (MRG003) Plus Pucotenlimab (HX008) in Oral Cavity Squamous Cell Carcinoma
PHASE2This is a phase 2, open-label, single-arm clinical trial evaluating neoadju...
Location
Hospital of Stomatology, Sun Yat-sen University
MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC
PHASE2This study enrolls patients who have experienced local recurrence of nasoph...
Location
Multiple Locations
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
PHASE1There is a significant unmet medical need for effective therapies for pedia...
Location
Sun Yat-sen University Cancer Center
Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma
PHASE2Advanced gastric cancer (AGC) and gastroesophageal junction (GEJ) adenocarc...
Location
Multiple Locations